Error: Could not add to watchlist. X
+ Watchlist

Mateon Therapeutics Inc

MATN:US
OTC US
0.365
USD
0.020
5.19%
As of 8:10 PM EDT 6/26/2017
Open
0.390
Day Range
0.350 - 0.390
Volume
103,236
Previous Close
0.385
52Wk Range
0.272 - 0.889
1 Yr Return
-46.32%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.390
Day Range
0.350 - 0.390
Volume
103,236
Previous Close
0.385
52Wk Range
0.272 - 0.889
1 Yr Return
-46.32%
YTD Return
0.72%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.540
Market Cap (m USD)
9.689
Shares Outstanding (m)
26.545
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Mateon Therapeutics, Inc. operates as a pharmaceutical company that develops therapeutics to treat cancer and eye diseases. The Company focuses on the clinical advancement of drug candidates that selectively disrupt abnormal blood vessels associated with solid tumor progression and visual impairment.
Address
701 Gateway Blvd
Suite 210
South San Francisco, CA 94080
United States
Phone
1-650-635-7000
  • William D Schwieterman "Bill"
    Chairman/President/CEO
  • Matthew M Loar
    CFO/Investor Relations
  • David J Chaplin "Dai"
    Chief Scientific Officer
  • Jeff Nelson
    VP:Program Management
Show More